openPR Logo
Press release

The Antiplatelet Drugs Market To Thrive Backed By Wearable Technology

08-22-2022 07:35 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Antiplatelet Drugs Market To Thrive Backed By Wearable

Antiplatelet drugs are incorrectly referred to as blood thinners. They do not thin the blood, but interfere with the vital process by which the blood clots. Antiplatelet drugs usually reduce the aggregation of blood cells, reducing potentially harmful clots. Giving antiplatelet drugs to people at high risk of heart disease can help avoid the risk of stroke and heart attack .

Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/17062

Antiplatelet drugs are widely used in heart attack patients because most heart attacks are caused by blood clots in the arteries that supply the heart muscle. It is also used for patients undergoing surgical procedures, such as angioplasty, where a tube called a stent is inserted to unblock an artery .

Antiplatelet Drugs market is expected to drive during the forecast period owing to increasing organic and inorganic growth within the industry. In addition, the generic market is also growing, revitalizing generic antiplatelet manufacturers. The amount the company spends on research and development is also expected to contribute to the revenue of the antiplatelet market in the future. For example, in February 2017, PLx Pharma published positive antiplatelet data for its Aspertec drug in the Journal of the American College of Cardiology (JACC). Now, researchers are focusing on analyzing pharmacodynamics and meta-analysis to determine if one drug has an advantage over another.

Request Table of Contents @ https://www.persistencemarketresearch.com/toc/17062

Antiplatelet Drugs Market: Segmentation
depending on the type of drug
• aspirin
• Clopidogrel
• tikageler
• Prasugrel
• dipyridamole
• ticlopidine
• Absiximab
• tirofiban
• Etc

Based on application
• myocardial infarction
• Percutaneous coronary intervention
• angioplasty
• arterial thrombosis
• dental surgery
• Etc

By end-user
• hospital
• clinic
• emergency service center
• outpatient surgery center
• Etc

Aspirin is a very well-known antiplatelet drug that has been used for a very long time. In addition to aspirin, there are three drugs that received FDA approval in the 1990s. Plavix in 1997, Ticlid in 1991, Aggrenox in 1999. After this series of drugs, Effient was approved by the FDA in 2009. Antiplatelet drugs are just one type of drug used to treat people with stroke and heart attack. Antiplatelet drugs are usually given along with other antithrombotic drugs, lifestyle changes, and non-drug treatments to keep the heart healthy .

Access Full Report @ https://www.persistencemarketresearch.com/checkout/17062

Geographically, the Antiplatelet Drugs market has been segmented into 5 regions including North America, Asia Pacific, Middle East & Africa, Latin America & Europe. North America is the region with the highest number of players starting clinical trials for antiplatelet drugs. There are also many academic universities that receive research grants to develop new product alternatives. For example, Kengreal, an intravenous antiplatelet drug developed by The Medicines Company, is FDA-approved. Asia Pacific is expected to lead during the forecast period as it is an economically developing country.

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Antiplatelet Drugs Market To Thrive Backed By Wearable Technology here

News-ID: 2710906 • Views:

More Releases from Persistence Market Research

Snack Food Packaging Market Size to Reach US$34.8 Billion by 2033 - Persistence Market Research
Snack Food Packaging Market Size to Reach US$34.8 Billion by 2033 - Persistence …
The snack food packaging market has become an essential component of the global food and beverage ecosystem, driven by evolving consumer lifestyles, growing urbanization, and the rising demand for convenient food solutions. Snack foods such as chips, bakery snacks, confectionery, nuts, cereal bars, and extruded products require packaging that not only preserves freshness and taste but also enhances shelf appeal and portability. Packaging plays a critical role in protecting snack
Recycled Glass Market Size to Reach US$7.5 Billion by 2033 - Persistence Market Research
Recycled Glass Market Size to Reach US$7.5 Billion by 2033 - Persistence Market …
The recycled glass market has emerged as a vital pillar of the global circular economy, driven by increasing environmental awareness, regulatory pressure to reduce landfill waste, and the inherent recyclability of glass as a material. Recycled glass, often referred to as cullet, is produced from post consumer and post industrial glass waste and reused across a wide range of applications including container glass manufacturing, construction materials, fiberglass insulation, abrasives, and
India Synthetic Automotive Engine Oil Market Size Likely to Reach US$ 1,035.8 Million by 2033 - Persistence Market Research
India Synthetic Automotive Engine Oil Market Size Likely to Reach US$ 1,035.8 Mi …
The India synthetic automotive engine oil market is undergoing a structural transformation as the country's automotive ecosystem evolves toward higher performance, efficiency, and regulatory compliance. Synthetic engine oils are formulated using chemically engineered base stocks that deliver superior lubrication, thermal stability, and engine protection compared to conventional mineral oils. In India, the adoption of synthetic automotive engine oil has accelerated due to rising vehicle ownership, increasing average vehicle age, and
Composite Pipes Market Set to Reach US$4.0 Billion by 2033 - Persistence Market Research
Composite Pipes Market Set to Reach US$4.0 Billion by 2033 - Persistence Market …
The composite pipes market has gained significant momentum over the past decade as industries increasingly seek durable, corrosion resistant, and cost efficient piping solutions for demanding applications. Composite pipes are manufactured using a combination of materials such as fiberglass, resin, polymers, and reinforcement fibers to deliver superior mechanical strength, chemical resistance, and extended service life compared to conventional metal pipes. These properties make composite pipes an attractive alternative across sectors

All 5 Releases


More Releases for Antiplatelet

Antiplatelet Market Analysis 2024: Size, Share & Growth Report 2032
Allied Market Research added new research on Antiplatelet Market- Global Opportunity Analysis and Industry Forecast, 2022-2032. The Antiplatelet market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon,
Antiplatelet Market To Witness Strong Growth by 2032 | Astrazeneca, Novartis, Pf …
Allied Market Research added new research on Antiplatelet Market- Global Opportunity Analysis and Industry Forecast, 2022-2032. The Antiplatelet market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon,
Empowering Lives: Antiplatelet Drugs Market Trends
In 2023, the global antiplatelet drugs market reached an impressive value of USD 2.2 billion. This remarkable growth has been spurred by significant advancements in the pharmaceutical industry and a concerning increase in cases of thrombosis, which encompasses both arterial and venous conditions. As we look ahead to the forecast period of 2024-2032, the market is expected to continue its robust expansion, with a projected compound annual growth rate (CAGR)
Antiplatelet Market: Advancements in Preventing Blood Clotting Disorders
Allied Market Research Analyst have added a new research study on Title Antiplatelet Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon Inc., Eli Lilly, Bayer AG, Daiichi Sankyo Co. Ltd., Merck, Johnson & Johnson, Novartis, and Pfizer Inc., F.Hoffmann-La Roche AG, Astrazeneca. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies
Antiplatelet Drugs Market - Increasing incidence of cardiovascular diseases is e …
The report presents an in-depth assessment of the Antiplatelet Drugs Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of
Antiplatelet Drugs Market Size, Status, Global Demand and Growth Opportunities 2 …
The Global Antiplatelet Drugs Market report provides a detailed analysis of the market by end-user (replacement and OEM) and geography (APAC, Europe, MEA, North America, and South America). The report analyzes the market’s competitive landscape and offers information on several Antiplatelet Drugs including Eli Lilly, Alexion, Merck, Amgen, Bristol-Myers Squibb, Pfizer, Sanofi, Roche, Boehringer Ingelheim, GSK. The report also takes into account the impact of the novel COVID-19 pandemic on